MannKind has completed the Phase 3 clinical study of Afrezza (insulin human [rDNA origin]) in patients with type 1 diabetes and expects to release the data in the summer of 2013. Administered using MannKind's next-generation inhaler, the ...
Global healthcare company Novo Nordisk has announced plans to launch its obesity treatment drug, liraglutide, in the US by the end of 2014. Novo chief scientific officer Mads Thomsen was quoted by health24.com as saying that liraglutide ...
Tags: Obesity Drug, Medicine
The US Food and Drug Administration (FDA) has cleared Oramed's investigational new drug (IND) application for ORMD-0801, an oral insulin capsule, allowing the company to begin clinical trials of the drug. ORMD-0801 is an orally ingestible ...
Tags: FDA, Oral Insulin Capsule
Tactio Health Group has introduced TactioDiabetes, a diabetes management tool that is used to track glucose / A1C tracking, medication tracking, insulin adjustments, carb to insulin ratio, diabetes specific health coaching and many more. ...
Tags: Tactio Health, Management Tool
Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin. R U-500 insulin is a regular U-500 ...
Tags: Insulet, Eli Lilly, Insulin Pump
At the pharmaceutical trade fair Interphex in New York, SCHOTT Pharmaceutical Systems will be presenting the world’s first cartridges that have been developed specifically for the use on high-speed filling lines. The new design ...
Tags: SCHOTT, Cartridge Design
Injex Pharma's wholly owned subsidiary Injex Pharma GmbH has obtained the Chinese State Food and Drug Administration (SFDA) registration for its Injex30 needle free injection system. The Germany-based company registered the Injex30 with ...
Tags: Injex Pharma, Chinese Registration, Free Injection System
Microsoft is working on designs for a touch-enabled smart watch, joining a number of other large competitors like Samsung Electronics and Apple who are said to be working on similar devices, a newspaper reported. Executives at suppliers ...
Tags: Microsoft, Smart Watches
Mercodia, a developer of immunoassays, has entered into a collaboration agreement with Profil Institute for Clinical Research. Under the alliance, Mercodia will offer its enzyme-linked immnosorbent assays (ELISA) as a component for Profil ...
Tags: Profil Institute, Mercodia, Clinical
Several weeks ago I found myself in a very uncomfortable position — behind the microphone rather than in front of it taking notes and snapping photos for articles in Western Farm Press. Good friend and Northern California UCCE Farm ...
Tags: Farm, biotechnology, Agriculture
Tianjin Food and Drug Administration has granted regulatory approval to Novo Nordisk to market its new insulin delivery device in China. The NovoPen 5 device, which has the same benefits as its predecessor NovoPen 4 in terms of the design ...
Tags: Novo Nordisk, Chinese Approval, Insulin Delivery Device
CeQur has reported its PaQ insulin delivery device initial study data at the 6th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France. The discreet, wearable CE-marked device, which comprises ...
Tags: CeQur, PaQ insulin delivery device, insulin infuser reservoir
The Gerresheimer Group’s high quality pharmaceutical packaging products and systems are part of a leading international portfolio. The products are manufac-tured in diverse designs, to a wide range of specifications and tailored to ...
Tags: Gerresheimer Group, pharmaceutical packaging products, moulded glass
Swiss-based medical devices firm Debiotech has entered into an exclusive partnership agreement with Valtronic for the manufacturing of the electronic Controller unit for Debiotech's insulin product JewelPUMP. The insulin pump, which is ...
Tags: insulin pump, medical devices, JewelPUMP
Novo Nordisk has received an approval of the price from Japan's Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare, and is set to launch Tresiba (insulin degludec) in ...
Tags: diabetes therapy, Medical, Novo Nordisk